The Visible Management Team
Chairman and CEO
Stevens is the founder and major investor in VAI. He has 20 years of entrepreneurial business experience and has founded four other technology-based companies all with successful international products. The most recent Visible Genetics Inc. (VGIN), a Biotech company specializes in DNA sequencing and genotyping. He served as Chairman and CEO for nine years. During his tenure as CEO, he was responsible for a highly successful NASDAQ IPO, took the company from zero to annual revenues of $10.9 mm, with over 200 worldwide employees, and 500 customer sites. Under his leadership VGI developed its full product line of DNA sequencers, kits (HIV, HepC, HepB), software, created manufacturing facilities with all necessary cGMP quality systems, established world wide sales and support, had over 37 US patents issued or allowed with another 35 patents pending, obtained all necessary FDA clearance (IDE and Open Label approval) to proceed with its current FDA approved HIV genotyping program. Dr. Stevens holds a PhD. in biophysics from the University of Pennsylvania (1974), and has held positions at University of Pennsylvania (Associate Professor), University of Toronto (Tenured Full Professor), and was director of the Eye Research Inst. of Canada.
Vice President of Technology
and Corporate Counsel
Jason is responsible for the management of all legal issues, including but not limited to the protection of its intellectual property and corporate structure. He is also responsible for managing human resources and investor relations. Prior to joining VAI, Jason was Director of Patents and Licensing for Visible Genetics Inc., a publicly traded company on NASDAQ (VGIN). He also brings with him experience in private practice from the firm Gowling Lafleur Henderson LLP (formerly Gowling, Strathy & Henderson) where he maintained an intellectual property law practice specializing in the protection of biotechnology and software related patents, trademarks and copyrights in the firm's Toronto Office. Mr. August holds a Bachelor of Science specializing in Genetics from McGill University and a Law Degree from the University of Windsor where he completed a joint program in American and Canadian Intellectual Property Law at Wayne State University and the University of Detroit. He has written several intellectual property articles including publications in Patent World and IP World that focused on the topic of software patents in the United States and Canada. Mr. August is a member of the Law Society of Upper Canada, the Intellectual Property Institute of Canada (formerly the Patent and Trademark Institute of Canada) and the Canadian Bar Association.
Alexandre Izmailov, Vice President, Product Development – Brings to Visible Assets broad expertise in innovative design, system engineering, and knowledge of manufacturing processes, along with more than 20 years of experience in managing product development. Skilled at managing highly qualified multidisciplinary teams in hardware R&D, systems engineering and design transfer for cost effective manufacturing having done so in in a variety of technology fields including: biotechnology, lasers and spectroscopy. Was Director of Engineering at both Bayer Corporation and Siemens and VP of Product Development & Manufacturing with Xceed Molecular, Inc., and Axela, Inc. Doctor Izmailov hold a Ph.D. in Physics from St. Petersburg University and has authored over 25 patents.